These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29758553)

  • 1. A Retrospective Cohort Study on Patients with Hidradenitis Suppurativa.
    Seyed Jafari SM; Knüsel E; Cazzaniga S; Hunger RE
    Dermatology; 2018; 234(1-2):71-78. PubMed ID: 29758553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.
    Shanmugam VK; Mulani S; McNish S; Harris S; Buescher T; Amdur R
    Int J Dermatol; 2018 Jan; 57(1):62-69. PubMed ID: 29130482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
    Riis PT; Saunte DM; Sigsgaard V; Villani AP; Guillem P; Pascual JC; Kappe NN; Vanlaerhoven AMJD; van der Zee HH; Prens EP; El-Domyati M; Abdel-Wahab H; Moftah N; Abdelghani R; Agut-Busquet E; Romaní J; Hlela C; van den Worm L; Bettoli V; Calamo G; Gürer MA; Beksaç B; Matusiak L; Glowaczewska A; Szepietowski JC; Emtestam L; Lapins J; Kottb HR; Fatani M; Weibel L; Theiler M; Delage-Toriel M; Lam TTH; Nassif A; Becherel PA; Dolenc-Voljc M; Doss N; Bouazzi D; Benhadou F; Del Marmol V; Jemec GBE
    Arch Dermatol Res; 2020 Dec; 312(10):715-724. PubMed ID: 32166376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a combined pharmacological and surgical approach in patients affected by hidradenitis suppurativa: data from a retrospective real-world clinical study.
    Malvaso D; Chiricozzi A; Fossati B; Antonelli F; Peris K
    Ital J Dermatol Venerol; 2024 Apr; 159(2):190-195. PubMed ID: 38650499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.
    Porter ML; Golbari NM; Lockwood SJ; Kimball AB
    Semin Cutan Med Surg; 2018 Sep; 37(3):182-189. PubMed ID: 30215636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    Join-Lambert O; Coignard-Biehler H; Jais JP; Delage M; Guet-Revillet H; Poirée S; Duchatelet S; Jullien V; Hovnanian A; Lortholary O; Nassif X; Nassif A
    J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2017 Jan; 76(1):54-59. PubMed ID: 27692736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.
    Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH
    Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa in children and young adults: a retrospective cross-sectional observational study in the United Kingdom.
    McGrath C; Steyn M; Rashidghamat E
    Int J Dermatol; 2024 Jul; 63(7):904-906. PubMed ID: 38273707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.
    Orenstein LAV; Nguyen TV; Damiani G; Sayed C; Jemec GBE; Hamzavi I
    Dermatology; 2020; 236(5):393-412. PubMed ID: 32408306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilonidal Sinus Disease is Associated with Severe Hidradenitis Suppurativa in a Spanish Cohort.
    Ureña-Paniego C; Gamissans-Cañada M; Molina-Leyva A; Romaní J
    Acta Derm Venereol; 2023 Sep; 103():adv6569. PubMed ID: 37766657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study.
    Prens LM; Huizinga J; Janse IC; Horváth B
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1941-1946. PubMed ID: 31132177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Perspective on Isotretinoin Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review of Patient Outcomes.
    Huang CM; Kirchhof MG
    Dermatology; 2017; 233(2-3):120-125. PubMed ID: 28641306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and Clinical Features of Hidradenitis Suppurativa in Turkey.
    Yüksel M; Basım P
    J Cutan Med Surg; 2020; 24(1):55-59. PubMed ID: 31698918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide-10 in the adjuvant treatment of hidradenitis suppurativa: Real-life data.
    Skroza N; Mambrin A; Tolino E; Marchesiello A; Proietti I; Bernardini N; Potenza C
    Dermatol Ther; 2018 Jul; 31(4):e12599. PubMed ID: 29642279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.